Home Tools
Log in
Cart

Search Result

Search Results for " glucocerebrosidase "

17

Compounds

Cat No. Product Name Synonyms Targets
T78573 Glucocerebrosidase GCase,Glucosylceramidase Endogenous Metabolite
Glucocerebrosidase (Glucosylceramidase; GBA), a lysosomal enzyme, catalyzes the hydrolysis of the β-glucosidic linkage in glucocerebroside (GC) to yield glucose and ceramide [1].
T60353 Glucocerebrosidase-IN-1
Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC 50 of 29.3 μM and a K i of 18.5 μM. Due to GCase involvement in pathological disorders consequent to enzym...
T78671 Glucocerebrosidase-IN-1 hydrochloride Glucosidase
Glucocerebrosidase-IN-1 (compound 11a) hydrochloride is a potent, selective GCase (glucocerebrosidase) inhibitor with IC50 and Ki values of 29.3 μM and 18.5 μM, respectively. It is utilized in the research of Gaucher dis...
T8986 ML198 Glucokinase
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease.
T0920 Ambroxol Ambroxolum,NA-872 P450 , Autophagy
Ambroxol (NA-872) is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a muco...
T6234 Ambroxol hydrochloride Mucosolvan,Mucoangin,Ambroxol HCl Sodium Channel , Autophagy
Ambroxol hydrochloride (Mucosolvan) is a metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
T40544 NCGC00092410 ML008 Glucosidase
NCGC00092410 (ML008) is a glucocerebrosidase (GC) inhibitor with IC50 value of 31 nM. It can be used for the study of Gaucher disease caused by mutation of glucocerebrase gene.
T8989 NCGC 607 NCGC607 Others
NCGC 607 is a a noninhibitory chaperone of glucocerebrosidase (GCase).
T60048 WAY-640509 Glucokinase
WAY-640509 is a glucocerebrosidase inhibitor.
T4280 Gcase activator 1 LTI-291,LTI 291,LTI291 Glucosidase
Gcase activator 1 (LTI-291) is a glucocerebrosidase (Gcase) activator.
T8990 ML266 Glucokinase
ML266, a glucocerebrosidase (GCase) chaperone with an IC50 of 2.5 µM, facilitates the transport of the mutant protein to the lysosome, thereby restoring GCase activity without inhibiting the enzyme's function. This compo...
T39518 PFB-FDGlu Others
PFB-FDGlu is a lysosomal Glucocerebrosidase (GCase) substrate with cell-permeable specificity that is cleaved to produce fluorescein.PFB-FDGlu is often used in conjunction with a flow cytometer to measure GCase activity ...
T37440 C2 Adamantanyl Galactosylceramide (d18:1/2:0)
C2 Adamantanyl Galactosylceramide (d18:1/2:0) (AdaGalCer) is a bioactive sphingolipid. It reduces globotriaosylceramide 3 synthesis from exogenous lactosylceramide in microsomes. AdaGalCer stimulates recombinant glucocer...
T80994 Therapeutic agent-1
Therapeutic Agent-1, a heteroaryl compound, serves as an enzyme replacement therapy to enhance glucocerebrosidase activity in the treatment of Gaucher disease [1].
T78493 Glucosylsphingosine Lyso-Gb1,Glucopsychosine
Glucosylsphingosine (lyso-Gb1), a deacylated glucosylceramide derivative metabolized by glucocerebrosidase, serves as a promising, reliable, and specific biomarker for Gaucher disease monitoring [1].
T37928 13C6 Glucosylsphingosine (d18:1)
13C6 Glucosylsphingosine (d18:1) is an isotopically enriched form of 1-β-D-glucosylsphingosine (d18:1) that is intended for use as an internal standard for the quantification of 1-β-D-glucosylsphingosine by GC- or LC-MS....
T38213 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))
1-β-D-Glucosylsphingadienine is a glucosylsphingosine, which are deacetylated lysolipid derivatives of glucosylcerebrosides . They are formed when sphingosines undergo glucosidation by UDP-glucose. Glucosylsphingosines c...
TargetMol